Integration of single sign on (SSO) solution within cavatica and 6 months of a tier 1 cavatica license and options for subsequent cavatica licenses for 2024 and 2025.
Ended Purchase Order Awarded Last action
- Contract number
- 75N95023P00133
- Awardee
-
Seven Bridges Genomics Inc. UEI KHTTXQEGW995
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $349,650
Award facts
- Contract value 47% obligated
-
- $349,650.33 Current, with exercised options
- $749,650.33 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Charlestown, MA 02129, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,611 | |
| Exercise an Option | $119,888 | |
| Exercise an Option | $119,888 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $111,485 |
About this award
The National Institute on Drug Abuse awarded a purchase order to Seven Bridges Genomics Inc. for $749,650.33 on May 1, 2023, for integration of a Single Sign On solution within Cavatica and six months of a Tier 1 Cavatica license, with options for subsequent Cavatica licenses in 2024 and 2025. No set-aside applied. Performance occurs in Charlestown, Massachusetts. The contract carries a firm fixed price and completion date of October 31, 2025. In FY2024, the prime invoiced $137 thousand across 0.2 FTEs and 396 contractor hours at a derived rate of $345.17 per hour, with no subcontractors reported.
Quick answers
Who was awarded contract 75N95023P00133?
75N95023P00133 was awarded to Seven Bridges Genomics Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 1, 2023.
How much is contract 75N95023P00133 worth?
The government has obligated $349,650 on 75N95023P00133. Its potential value, with all options, is $749,650.
Was contract 75N95023P00133 competed?
The extent of competition for 75N95023P00133 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award